SQA
RDY icon

Simon Quick Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Simon Quick Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,199
Closed -$135K – 586
2025
Q1 		$135K Sell
10,199
-3,959
-28% -$54.6K 0.01% 585
2024
Q4 		$224K Buy
+14,158
New +$213K 0.01% 420

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simon Quick Advisors's RDY Position: Q2 2025 in Review

Simon Quick Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 10,199 shares — an estimated $135K sold.

Simon Quick Advisors first reported a position in RDY in Q4 2024 and held it in 2 quarters. The position peaked at $224K in Q4 2024. 242 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Simon Quick Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
  • Simon Quick Advisors sold 10,199 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $135K.
  • Simon Quick Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2024 and held it in 2 quarters.
  • Simon Quick Advisors's Dr. Reddy's Laboratories position peaked at $224K in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Simon Quick Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.